Bioelectronics involves integration of biology and electronics to develop medical and non-medical devices. Bioelectronics devices help monitor functions of various organs such as brain, heart, muscles and detecting various biochemicals and help in disease diagnosis & treatment. These innovative products allow convenient and continuous health monitoring in relatively inexpensive manner compared to traditional expensive healthcare methods.
The global bioelectronics market is estimated to be valued at US$ 23530 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
Remote Health Monitoring
The opportunity for remote health monitoring is driving the growth of the bioelectronics market. The bioelectronics devices allow continuous monitoring of vital body functions and send that data to healthcare providers. This enable early diagnosis of health issues and monitoring fitness levels from remote locations rather than visiting hospitals frequently. The biosensors integrated can help monitor ECG, blood glucose, blood pressure and other health parameters. This is expected to especially benefit aged population and people in rural areas with limited access to healthcare by improving health outcomes in a cost effective manner.
Porter's Analysis
Threat of new entrants: The bioelectronics market requires high capital investment for R&D activities which create entry barriers for new players.
Bargaining power of buyers: There exist a large number of buyers in the global healthcare sector giving them more bargaining power over the existing players.
Bargaining power of suppliers: The requirement of specialized components and equipment for bioelectronics manufacturing gives suppliers an edge in the market.
Threat of new substitutes: Continuous innovations in bioelectronics and related technologies provide opportunities for new substitutes to emerge.
Competitive rivalry: The global market is highly fragmented with the presence of numerous global and regional players leading to fierce competition.
SWOT Analysis
Strengths: Emerging applications across healthcare diagnostics and medical devices has boosted R&D spending.
Weaknesses: High costs associated with commercialization of new bioelectronic products. Dependence on reimbursement policies impacts adoption of new technologies.
Opportunities: Growing aging population drives the demand for remote patient monitoring solutions. Investments into nano- and microelectronics open new opportunities.
Threats: Stringent regulatory framework impacts timely approvals and market introduction of novel products. Data privacy and security concerns affect consumer confidence.
Key Takeaways
The Global Bioelectronics Market Share is expected to witness high growth with expanding applications across multiple domains including implantable and wearable devices.
Regional analysis: North America dominates the market holding over 35% share due to presence of key industry players and strong government support for research activities in the US and Canada. Asia Pacific shows high growth potential led by China, Japan and India on back of increasing healthcare spending, rising disposable incomes and growing medical tourism.
Key players operating in the bioelectronics market are BBI-Biotech GmbH Bioengineering AG, Danaher Corporation, Eppendorf AG, Getinge, Infors HT, Merck KGAASartorius AG, Solaris Biotech Solutions, and Thermo Fisher Scientific, Inc. Major players are focusing on new product launches and mergers & acquisitions to strengthen their market position.
Get More Insights Here
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian